Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Endovascular Treatment for Acute High-risk Type B Aortic Dissection in Acute VS Subacute Phase: a Prospective, Multicenter, Non-inferior, Parallel Controlled Trial

NCT07143071 is registered in ClinicalTrials.gov with Shanghai Zhongshan Hospital as lead sponsor.

NCT NCT07143071
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07143071 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Endovascular Treatment for Acute High-risk Type B Aortic Dissection in Acute VS Subacute Phase: a Prospective, Multicenter, Non-inferior, Parallel Controlled Trial
Lead sponsor
Shanghai Zhongshan Hospital
Phase
Observational
Overall status
Active, not recruiting
Start date
July 1, 2025
Completion date
July 31, 2030
Enrollment
4,068 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

aortic dissection type b